Home - Products - Others - Other Targets - 3-(Dodecylamino)propane-1,2-diol

3-(Dodecylamino)propane-1,2-diol

CAS No. 821-91-0

3-(Dodecylamino)propane-1,2-diol( —— )

Catalog No. M37472 CAS No. 821-91-0

3-(Dodecylamino)propane-1,2-diol (3-(Dodecylamino)propane-1,2-diol) is a surfactant that can be used to prepare nanomicelles.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 29 In Stock
50MG 37 In Stock
100MG 53 In Stock
200MG 77 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-(Dodecylamino)propane-1,2-diol
  • Note
    Research use only, not for human use.
  • Brief Description
    3-(Dodecylamino)propane-1,2-diol (3-(Dodecylamino)propane-1,2-diol) is a surfactant that can be used to prepare nanomicelles.
  • Description
    3-(Dodecylamino)propane-1,2-diol (3-(Dodecylamino)propane-1,2-diol) is a surfactant that can be used to prepare nanomicelles.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    821-91-0
  • Formula Weight
    259.43
  • Molecular Formula
    C15H33NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OCC(O)CNCCCCCCCCCCCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Lancerin

    Lancerin, isolated from the root bark of Cudraniu cochinchinensis, possesses anti-lipid peroxidation.

  • Dibenzosuberol

    It is an organic compound used as Pharmaceutical intermediate.

  • Kyotorphin

    Kyotorphin is an endogenou neuroactive dipeptide with analgesic properties. Kyotorphin possesses anti-inflammatory and antimicrobial activity. Kyotorphin levels in cerebro-spinal fluid correlate negatively with the progression of neurodegeneration in Alzheimer's Disease patients.